Beyond Air (XAIR) Income from Continuing Operations (2016 - 2026)
Beyond Air (XAIR) reported Income from Continuing Operations of 10368000.0 for Q1 2026, down 130.38% on a YoY basis from 34123000.0 in Q1 2025, and down 35.88% sequentially from 7630000.0 in Q4 2025.
Beyond Air (XAIR) Income from Continuing Operations (2016 - 2026) Analysis & Trends
Beyond Air (XAIR) has 11 years of Income from Continuing Operations data on file, last reported at 10368000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 130.38% year-over-year to 10368000.0; the trailing twelve-month figure through Mar 2026 stood at 34334000.0 (down 445.5% YoY), and the FY2026 full-year result was 27124000.0, down 331.02% from the prior year.
- Income from Continuing Operations fell to 10368000.0 in Q1 2026, from 7630000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 34123000.0 in Q1 2025 to a low of 37496000.0 in Q4 2022.
- A 5-year average of 12966705.88 and a median of 14029000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations sank 318.28% in 2022 and jumped 334.43% in 2025, its largest moves.
- Tracing XAIR's Income from Continuing Operations over 5 years: stood at 37496000.0 in 2022, then soared by 53.97% to 17258000.0 in 2023, then climbed by 22.74% to 13333000.0 in 2024, then soared by 42.77% to 7630000.0 in 2025, then tumbled by 35.88% to 10368000.0 in 2026.
- Business Quant data shows XAIR's Income from Continuing Operations at 10368000.0 in Q1 2026, 7630000.0 in Q4 2025, and 8258000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Beyond Air | 2.25 Mn | -10.02 Mn | 94,000.00 | -10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.37 Mn |
| Dec 31, 2025 | -7.63 Mn |
| Sep 30, 2025 | -8.26 Mn |
| Jun 30, 2025 | -8.08 Mn |
| Mar 31, 2025 | 34.12 Mn |
| Dec 31, 2024 | -13.33 Mn |
| Sep 30, 2024 | -14.03 Mn |
| Jun 30, 2024 | -13.06 Mn |
| Mar 31, 2024 | -14.56 Mn |
| Dec 31, 2023 | -17.26 Mn |
| Sep 30, 2023 | -17.43 Mn |
| Jun 30, 2023 | -15.06 Mn |
| Mar 31, 2023 | -13.88 Mn |
| Dec 31, 2022 | -37.50 Mn |
| Sep 30, 2022 | -25.38 Mn |
| Jun 30, 2022 | -18.32 Mn |
| Mar 31, 2022 | -20.44 Mn |
| Dec 31, 2021 | -25.11 Mn |
| Sep 30, 2021 | -32.42 Mn |
| Jun 30, 2021 | -13.11 Mn |